🇺🇸 FDA
Patent

US 8349888

Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury

granted A61KA61K31/352A61K31/7048

Quick answer

US patent 8349888 (Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/352, A61K31/7048, A61K36/48, A61K41/00